SB 271 is aimed primarily at reigning in highly-concentrated delta-8 products
Colorado lawmakers say they have worked out a compromise in proposed legislation stakeholders had feared would place overly strict limits on CBD.
The measure, Senate Bill 271 (SB 271), is aimed primarily at reigning in highly-concentrated delta-8 THC products, which are synthetically produced from hemp-derived CBD in the lab. The products, which produce a “high” that mimics that of marijuana-derived delta-9 THC, have flourished in Colorado and other states amid safety concerns due to regulatory gaps.
While SB 271 would put up guardrails for delta-8 by placing the compound under rules for delta-9 (marijuana) products, stakeholders complained that limits in a proposed amendment to the bill would have deprived consumers of access to over-the-counter CBD products, which are legal and can be sold outside of the state’s marijuana dispensaries.
To Read The Rest Of This Article On Hemp Today, Click Here